DHR vs MA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Mastercard Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Mastercard Incorporated · Financial Services
$574.42
+25.0% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MA |
| Current Price |
$221.12 |
$574.42 |
| Fair Value Estimate |
$286.52 |
$718.00 |
| Upside to Fair Value |
+29.6%
|
+25.0%
|
| Market Cap |
$155.4B |
$503.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
23.4x
|
| Price / Sales |
6.2x
|
14.4x
|
| Price / FCF |
28.5x
|
30.8x
|
| Revenue Growth YoY |
+5.5%
|
+14.1%
|
| Gross Margin |
58.5%
|
100%
|
| Operating Margin |
20.4%
|
59.8%
|
| Return on Equity |
7.7%
|
232.5%
|
| Dividend Yield |
0.65% |
0.59% |
| FCF Yield |
3.51%
|
3.25%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Mastercard operates a global payments network that connects issuers, acquirers, merchants and consumers across more than 200 countries and territories, monetizing payment volumes, cross-border activity and higher-growth value-added services. Business quality is high because its two-sided network, trusted authorization-clearing-settlement infrastructure, brand, security capabilities and broad acce…
Accumulation Zones
| Metric |
DHR |
MA |
| Zone Low |
$214.89 |
$538.50 |
| Zone High |
$243.54 |
$610.30 |
| In Buy Zone? |
Yes
|
Yes
|